Contineum Therapeutics (CTNM) Q3 2025 Earnings

Aug 5Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.62
-0.55
-0.47
-0.4

Details

Expected EPS
-0.440386
Actual EPS
-0.62
Surprise EPS
-0.18
Surprise Percent
-40.79%

Description

⁨Contineum Therapeutics⁩ (⁦CTNM⁩) has reported earnings of ⁦-0.62⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts